MXPA01013407A - Proceso para preparar amlodifpina bencenosulfonato. - Google Patents

Proceso para preparar amlodifpina bencenosulfonato.

Info

Publication number
MXPA01013407A
MXPA01013407A MXPA01013407A MXPA01013407A MXPA01013407A MX PA01013407 A MXPA01013407 A MX PA01013407A MX PA01013407 A MXPA01013407 A MX PA01013407A MX PA01013407 A MXPA01013407 A MX PA01013407A MX PA01013407 A MXPA01013407 A MX PA01013407A
Authority
MX
Mexico
Prior art keywords
methyl
benzenesulphonate
preparing amlodipine
amlodipine benzenesulphonate
formula
Prior art date
Application number
MXPA01013407A
Other languages
English (en)
Inventor
Fischer Janos
Original Assignee
Richardson Merrell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell filed Critical Richardson Merrell
Publication of MXPA01013407A publication Critical patent/MXPA01013407A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
MXPA01013407A 1999-07-05 1999-07-05 Proceso para preparar amlodifpina bencenosulfonato. MXPA01013407A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/HU1999/000050 WO2001002360A1 (en) 1999-07-05 1999-07-05 Process for preparing amlodipine benzenesulphonate

Publications (1)

Publication Number Publication Date
MXPA01013407A true MXPA01013407A (es) 2003-09-04

Family

ID=10991279

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01013407A MXPA01013407A (es) 1999-07-05 1999-07-05 Proceso para preparar amlodifpina bencenosulfonato.

Country Status (24)

Country Link
US (1) US6596874B1 (es)
EP (1) EP1196383B1 (es)
JP (1) JP3764386B2 (es)
KR (1) KR100585442B1 (es)
CN (1) CN1141297C (es)
AT (1) ATE283841T1 (es)
AU (1) AU777565B2 (es)
BG (1) BG65657B1 (es)
CA (1) CA2376540C (es)
CZ (1) CZ300509B6 (es)
DE (1) DE69922417T2 (es)
DK (1) DK1196383T3 (es)
EA (1) EA004208B1 (es)
EE (1) EE05398B1 (es)
ES (1) ES2234272T3 (es)
HK (1) HK1044151B (es)
MX (1) MXPA01013407A (es)
NO (1) NO321714B1 (es)
NZ (1) NZ517013A (es)
PL (1) PL194193B1 (es)
PT (1) PT1196383E (es)
SK (1) SK285611B6 (es)
UA (1) UA72768C2 (es)
WO (1) WO2001002360A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100354806B1 (ko) * 2000-06-21 2002-10-05 한국유나이티드제약 주식회사 암로디핀 베실레이트의 신규 중간체 및 그의 제조방법
ATE454890T1 (de) 2001-07-06 2010-01-15 Lek Pharmaceuticals Verfahren zur herstellung hochreines amlodipinbenzolsulfonat
US6680334B2 (en) 2001-08-28 2004-01-20 Pfizer Inc Crystalline material
AR037565A1 (es) * 2001-11-21 2004-11-17 Synthon Bv Formas de sales de amlodipina y procedimientos para prepararlas.
KR100496436B1 (ko) * 2002-07-30 2005-06-20 씨제이 주식회사 암로디핀의 유기산염
KR100462304B1 (ko) * 2002-07-30 2004-12-17 씨제이 주식회사 암로디핀의 유기산염
KR100467669B1 (ko) * 2002-08-21 2005-01-24 씨제이 주식회사 암로디핀의 유기산염
US6784297B2 (en) 2002-09-04 2004-08-31 Kopran Limited Process for the preparation of anti-ischemic and anti-hypertensive drug amlodipine besylate
JP2008013489A (ja) * 2006-07-06 2008-01-24 Ohara Yakuhin Kogyo Kk ベシル酸アムロジピン含有錠剤
EP1975167A1 (en) 2007-03-30 2008-10-01 Esteve Quimica, S.A. Acetone solvate of phthaloyl amlodipine
CN101812014B (zh) * 2010-04-28 2011-08-24 王明 一种苯磺酸氨氯地平化合物及其制法
CN102993083A (zh) * 2012-12-21 2013-03-27 王学军 一种苯磺酸氨氯地平的制备方法
CN104262237A (zh) * 2014-09-28 2015-01-07 常州瑞明药业有限公司 氨氯地平自由碱的合成方法
US11452690B1 (en) 2021-01-27 2022-09-27 ECI Pharmaceuticals, LLC Oral liquid compositions comprising amlodipine besylate and methods of using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
SI9200344B (sl) * 1992-11-26 1998-06-30 Lek, Postopek za pripravo amlodipin benzensulfonata
HU221810B1 (hu) * 1997-08-12 2003-01-28 EGIS Gyógyszergyár Rt. Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei
DE19738943B4 (de) 1997-09-05 2008-01-03 Siemens Ag Verfahren und Einrichtung zur Bestimmung von Eigenschaften eines Stahls

Also Published As

Publication number Publication date
WO2001002360A1 (en) 2001-01-11
NO20020029L (no) 2002-03-05
UA72768C2 (en) 2005-04-15
EE05398B1 (et) 2011-04-15
DE69922417T2 (de) 2005-12-01
NO321714B1 (no) 2006-06-26
EP1196383A1 (en) 2002-04-17
SK22002A3 (en) 2002-05-09
ATE283841T1 (de) 2004-12-15
BG65657B1 (bg) 2009-05-29
BG106164A (en) 2002-07-31
HK1044151B (zh) 2004-09-10
DE69922417D1 (de) 2005-01-05
AU777565B2 (en) 2004-10-21
SK285611B6 (sk) 2007-04-05
NO20020029D0 (no) 2002-01-04
EE200100686A (et) 2003-04-15
CN1352634A (zh) 2002-06-05
CA2376540A1 (en) 2001-01-11
CZ20014690A3 (cs) 2002-04-17
PL352493A1 (en) 2003-08-25
ES2234272T3 (es) 2005-06-16
EA200200125A1 (ru) 2002-06-27
HK1044151A1 (en) 2002-10-11
JP3764386B2 (ja) 2006-04-05
NZ517013A (en) 2003-08-29
DK1196383T3 (da) 2005-02-21
PT1196383E (pt) 2005-03-31
US6596874B1 (en) 2003-07-22
CA2376540C (en) 2007-03-13
KR100585442B1 (ko) 2006-06-02
PL194193B1 (pl) 2007-05-31
KR20020022760A (ko) 2002-03-27
AU4923799A (en) 2001-01-22
EA004208B1 (ru) 2004-02-26
EP1196383B1 (en) 2004-12-01
CZ300509B6 (cs) 2009-06-03
JP2003503477A (ja) 2003-01-28
CN1141297C (zh) 2004-03-10

Similar Documents

Publication Publication Date Title
HK1044151A1 (en) Process for preparing amlodipine benzenesulphonate
CA2384283A1 (en) Process for preparing 4-trifluoromethylsulphinylpyrazole derivative
AU2001269388A1 (en) New processes for the production of fexofenadine
WO2002053535A3 (en) Process for making amlodipine, derivatives thereof, and precursors therefor
YU76500A (sh) Hemijska sinzeza morfolinskih derivata
AP9901698A0 (en) Novel process.
DK1206452T3 (da) Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser
HK1037617A1 (en) Process for the preparation of imidazodiazepine intermediates
HU0201673D0 (es)
ZA200208986B (en) Process for the preparation of pesticidal compounds.
EP1319646A4 (en) PROCESS FOR THE PREPARATION OF 3,5-BISALKYLPHENOLENE
WO1999057095A3 (en) Process for the preparation of a pharmaceutical intermediate
AU1499902A (en) Method for producing 1 substituted 5-chloro-4 methyl pyrazoles
HUP0002772A2 (hu) Eljárás királis 3,4-dehidroprolinok előállítására
WO2002018364A3 (en) Process for preparing 2-phenyl-3-aminobenzothiophenes
IL158530A0 (en) Method for producing 1,3-disubstituted 2-nitroguanidines
RS20100109A (en) Process for preparing 4-trifluoromethzlsulphinylpyrazole derivative
RS20100110A (en) Process for preparing 4- trifluoromethylsulphinylpyrazole derivative

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees